M/I Homes, Inc. (MHO)
NYSE: MHO · Real-Time Price · USD
126.27
+3.63 (2.96%)
Aug 4, 2025, 4:00 PM - Market closed
ShockWave Medical Stock Forecast
Stock Price Forecast
The 3 analysts that cover ShockWave Medical stock have a consensus rating of "Strong Buy" and an average price target of $158.67, which forecasts a 25.66% increase in the stock price over the next year. The lowest target is $140 and the highest is $185.
Price Target: $158.67 (+25.66%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 29, 2025.
Analyst Ratings
The average analyst rating for ShockWave Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Maintains $168 → $140 | Strong Buy | Maintains | $168 → $140 | +10.87% | Apr 29, 2025 |
| Seaport Global | Seaport Global | Hold → Strong Buy Upgrades $151 | Hold → Strong Buy | Upgrades | $151 | +19.59% | Mar 6, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $210 → $168 | Strong Buy | Reiterates | $210 → $168 | +33.05% | Jan 30, 2025 |
| Wedbush | Wedbush | Hold → Buy Upgrades $185 | Hold → Buy | Upgrades | $185 | +46.51% | Nov 4, 2024 |
| Seaport Global | Seaport Global | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Aug 28, 2024 |
Financial Forecast
Revenue This Year
4.41B
from 4.50B
Decreased by -2.12%
Revenue Next Year
4.55B
from 4.41B
Increased by 3.24%
EPS This Year
17.17
from 19.71
Decreased by -12.90%
EPS Next Year
17.85
from 17.17
Increased by 3.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.7B | 4.9B | 5.3B |
| Avg | 4.4B | 4.6B | 5.1B |
| Low | 4.2B | 4.2B | 4.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.3% | 11.7% | 15.7% |
| Avg | -2.1% | 3.2% | 11.3% |
| Low | -7.5% | -4.8% | 8.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 19.83 | 21.74 |
| Avg | 17.17 | 17.85 |
| Low | 15.04 | 13.67 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 0.6% | 26.7% |
| Avg | -12.9% | 4.0% |
| Low | -23.7% | -20.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.